(Q45830734)

16 December 2017

title

An immunological biomarker to predict MTX response in early RA. (English)

1 reference

16 December 2017

0 references

10

1 reference

16 December 2017

Edward Marc Vital

8

Edward M Vital

1 reference

16 December 2017

Paul Emery

12

Paul Emery

1 reference

16 December 2017

Yasser Mohamed El-Sherbiny

Yasser El-Sherbiny

4

0 references

Agata N Burska

Agata Burska

7

0 references

Elizabeth M A Hensor

Elizabeth Hensor

11

0 references

author name string

Frederique Ponchel

1

1 reference

16 December 2017

Vincent Goëb

2

1 reference

16 December 2017

Rekha Parmar

3

1 reference

16 December 2017

Marjorie Boissinot

5

1 reference

16 December 2017

Jehan El Jawhari

6

1 reference

16 December 2017

Stephanie Harrison

9

1 reference

16 December 2017

language of work or name

English

0 references

publication date

29 August 2013

1 reference

16 December 2017

Annals of the Rheumatic Diseases

published in

1 reference

16 December 2017

volume

73

1 reference

16 December 2017

issue

11

1 reference

16 December 2017

page(s)

2047-2053

1 reference

16 December 2017

Rheumatoid arthritis. Pathophysiology and implications for therapy

cites work

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203566

Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203566

Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twe

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203566

Combination etanercept and methotrexate provides better disease control in very early (<=4 months) versus early rheumatoid arthritis (>4 months and <2 years): post hoc analyses from the COMET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203566

Treating rheumatoid arthritis to target: recommendations of an international task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203566

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203566

Predictors for remission in rheumatoid arthritis patients: A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203566

CD4+T-cell subsets in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203566

Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203566

Interleukin-7 deficiency in rheumatoid arthritis: consequences for therapy-induced lymphopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203566

Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203566

Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203566

Elucidation of the relationship between synovitis and bone damage: A randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203566

Abnormal T cell differentiation persists in patients with rheumatoid arthritis in clinical remission and predicts relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203566

Inhibition of human CD4(+)CD25(+high) regulatory T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203566

Control of regulatory T cell development by the transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203566

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203566

Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelve-week study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203566

Does the age of onset of rheumatoid arthritis influence phenotype?: a prospective study of outcome and prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203566

A good response to early DMARD treatment of patients with rheumatoid arthritis in the first year predicts remission during follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203566

Sex: a major predictor of remission in early rheumatoid arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203566

The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203566

The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203566

Outcome of intensive immunosuppression and autologous stem cell transplantation in patients with severe rheumatoid arthritis is associated with the composition of synovial T cell infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203566

Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis: Results from the British Society for Rheumatolo

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203566

Predictors of response to anti-TNF- therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203566

Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: Results from a large observational inception study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2013-203566

10.1136/ANNRHEUMDIS-2013-203566

21 January 2018

Identifiers

DOI

1 reference

16 December 2017

10.1136/ANNRHEUMDIS-2013-203566

Altmetric DOI

0 references

Dimensions Publication ID

1010634270

0 references

1 reference

16 December 2017